Bestewil Holding Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 3

Bestewil Holding General Information

Description

Producer of vaccines. The company engages in the development of a proprietary vaccine delivery platform (virosome) as well as intranasal influenza and RSV vaccines.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • Ant. Deusinglaan 1
  • 9713 AV Groningen
  • Netherlands
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Acquirer
Mymetics
Corporate Office
  • Ant. Deusinglaan 1
  • 9713 AV Groningen
  • Netherlands

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Bestewil Holding Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Bestewil Holding‘s full profile, request access.

Request a free trial

Bestewil Holding Patents

  • 48

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 26

    Granted

  • 000

    Pending

  • 000

    Expiring in next 12 mo

Bestewil Holding Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2014406150-B2 Methods for providing adjuvanted virosomes and adjuvanted virosomes obtainable thereby Active 12-Sep-2014 000000000 0
AU-2014406150-A1 Methods for providing adjuvanted virosomes and adjuvanted virosomes obtainable thereby Active 12-Sep-2014 000000000
CA-2960948-A1 Methods for providing adjuvanted virosomes and adjuvanted virosomes obtainable thereby Active 12-Sep-2014 000000000
US-10588963-B2 Methods for providing adjuvanted virosomes and adjuvanted virosomes obtainable thereby Active 12-Sep-2014 000000000 0
ES-2807607-T3 Methods for providing adjuvanted virosomes and adjuvanted virosomes obtainable in this manner Active 12-Sep-2014 A61K39/12
To view Bestewil Holding’s complete patent history, request access »

Bestewil Holding Executive Team (2)

Name Title Board Seat
Antonius Stegmann Co-Founder and Chief Scientific Officer
You’re viewing 1 of 2 executive team members. Get the full list »

Bestewil Holding Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Bestewil Holding‘s full profile, request access.

Request a free trial

Bestewil Holding FAQs

  • Who is the founder of Bestewil Holding?

    Antonius Stegmann is the founder of Bestewil Holding.

  • Where is Bestewil Holding headquartered?

    Bestewil Holding is headquartered in Groningen, Netherlands.

  • What industry is Bestewil Holding in?

    Bestewil Holding’s primary industry is Drug Discovery.

  • Is Bestewil Holding a private or public company?

    Bestewil Holding is a Private company.

  • What is the current valuation of Bestewil Holding?

    The current valuation of Bestewil Holding is 00.00.

  • What is Bestewil Holding’s current revenue?

    The current revenue for Bestewil Holding is 000000.

  • Who are Bestewil Holding’s investors?

    Norwood Immunology has invested in Bestewil Holding.

  • When was Bestewil Holding acquired?

    Bestewil Holding was acquired on 01-Apr-2009.

  • Who acquired Bestewil Holding?

    Bestewil Holding was acquired by Mymetics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »